Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hebert A Vargas

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Brachytherapy|March 25, 2016
Long-term outcome of magnetic resonance spectroscopic image-directed dose escalation for prostate brachytherapyMartin T King, Nicola J Nasser, Nitin Mathur, et al.
Abdominal Imaging|January 1, 2015
Preoperative CT-based nomogram for predicting overall survival in women with non-endometrioid carcinomas of the uterine corpusYulia Lakhman, Derya Yakar, Debra A Goldman, et al.
World Journal of Urology|October 30, 2015
Low yield of surveillance imaging after surgery for T1 kidney cancerMichael A Feuerstein, John E Musser, Matthew Kent, et al.
European Radiology|March 20, 2025
PSMA-avid rib lesions in prostate cancer patients: differentiating false positives from metastatic diseaseSungmin Woo, Anton S Becker, Doris Leithner, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 23, 2020
γ-Tocotrienol-Loaded Liposomes for Radioprotection from Hematopoietic Side Effects Caused by Radiotherapeutic DrugsSang-Gyu Lee, Teja Muralidhar Kalidindi, Hanzhi Lou, et al.
JAMA Oncology|June 5, 2016
Association of AR-V7 on Circulating Tumor Cells as a Treatment-Specific Biomarker With Outcomes and Survival in Castration-Resistant Prostate CancerHoward I Scher, David Lu, Nicole A Schreiber, et al.
Cancer Research|August 19, 2017
Phenotypic Heterogeneity of Circulating Tumor Cells Informs Clinical Decisions between AR Signaling Inhibitors and Taxanes in Metastatic Prostate CancerHoward I Scher, Ryon P Graf, Nicole A Schreiber, et al.
Annals of Surgical Oncology|October 30, 2015
Is It Time to Centralize Ovarian Cancer Care in the United States?Renee A Cowan, Roisin E O'Cearbhaill, Ginger J Gardner, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|December 14, 2019
Extensive disease among potential candidates for hemi-ablative focal therapy for prostate cancerToshikazu Takeda, Amy L Tin, Renato B Corradi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2021
Phase II Clinical Trial of Everolimus in a Pan-Cancer Cohort of Patients with mTOR Pathway AlterationsElio Adib, Katarzyna Klonowska, Krinio Giannikou, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Brachytherapy|March 25, 2016
Long-term outcome of magnetic resonance spectroscopic image-directed dose escalation for prostate brachytherapyMartin T King, Nicola J Nasser, Nitin Mathur, et al.
Abdominal Imaging|January 1, 2015
Preoperative CT-based nomogram for predicting overall survival in women with non-endometrioid carcinomas of the uterine corpusYulia Lakhman, Derya Yakar, Debra A Goldman, et al.
World Journal of Urology|October 30, 2015
Low yield of surveillance imaging after surgery for T1 kidney cancerMichael A Feuerstein, John E Musser, Matthew Kent, et al.
European Radiology|March 20, 2025
PSMA-avid rib lesions in prostate cancer patients: differentiating false positives from metastatic diseaseSungmin Woo, Anton S Becker, Doris Leithner, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 23, 2020
γ-Tocotrienol-Loaded Liposomes for Radioprotection from Hematopoietic Side Effects Caused by Radiotherapeutic DrugsSang-Gyu Lee, Teja Muralidhar Kalidindi, Hanzhi Lou, et al.
JAMA Oncology|June 5, 2016
Association of AR-V7 on Circulating Tumor Cells as a Treatment-Specific Biomarker With Outcomes and Survival in Castration-Resistant Prostate CancerHoward I Scher, David Lu, Nicole A Schreiber, et al.
Cancer Research|August 19, 2017
Phenotypic Heterogeneity of Circulating Tumor Cells Informs Clinical Decisions between AR Signaling Inhibitors and Taxanes in Metastatic Prostate CancerHoward I Scher, Ryon P Graf, Nicole A Schreiber, et al.
Annals of Surgical Oncology|October 30, 2015
Is It Time to Centralize Ovarian Cancer Care in the United States?Renee A Cowan, Roisin E O'Cearbhaill, Ginger J Gardner, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|December 14, 2019
Extensive disease among potential candidates for hemi-ablative focal therapy for prostate cancerToshikazu Takeda, Amy L Tin, Renato B Corradi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2021
Phase II Clinical Trial of Everolimus in a Pan-Cancer Cohort of Patients with mTOR Pathway AlterationsElio Adib, Katarzyna Klonowska, Krinio Giannikou, et al.
Pageof 6